Innovative medical management with resection for successful treatment of pulmonary mucormycosis despite diagnostic delay
- PMID: 12014459
Innovative medical management with resection for successful treatment of pulmonary mucormycosis despite diagnostic delay
Abstract
We present a case of primary pulmonary mucormycosis infection in a renal transplant recipient diagnosed serendipitously by computed tomography scan. Treatment included discontinuation of immunosuppressive regimen, initiation of antifungal therapy with amphotericin B lipid complex, administration of granulocyte-macrophage colony stimulating factor, surgical excision of the involved lobe, and outpatient treatment with amphotericin B with dialysis. The patient ultimately required transplant nephrectomy as a result of immunosuppression discontinuation.
Similar articles
-
Liposomal amphotericin B and surgery in the successful treatment of invasive pulmonary mucormycosis in a patient with acute T-lymphoblastic leukemia.Scand J Infect Dis. 2001;33(4):316-9. doi: 10.1080/003655401300077469. Scand J Infect Dis. 2001. PMID: 11345227
-
Successful treatment of invasive thoracopulmonary mucormycosis in a patient with acute lymphoblastic leukemia.Cancer. 1995 Sep 1;76(5):895-9. doi: 10.1002/1097-0142(19950901)76:5<895::aid-cncr2820760526>3.0.co;2-f. Cancer. 1995. PMID: 8625195
-
Successful eradication of mucormycosis occurring in a pulmonary allograft.J Heart Lung Transplant. 1999 Aug;18(8):801-4. doi: 10.1016/s1053-2498(99)00033-9. J Heart Lung Transplant. 1999. PMID: 10512529
-
Mucormycosis: New Developments into a Persistently Devastating Infection.Semin Respir Crit Care Med. 2015 Oct;36(5):692-705. doi: 10.1055/s-0035-1562896. Epub 2015 Sep 23. Semin Respir Crit Care Med. 2015. PMID: 26398536 Review.
-
[Pulmonary mucormycosis in a patient with diabetes mellitus: favorable evolution under medical treatment].Rev Fac Cien Med Univ Nac Cordoba. 2007;64(3):93-8. Rev Fac Cien Med Univ Nac Cordoba. 2007. PMID: 19928409 Review. Spanish.
Cited by
-
Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor (rhu GM-CSF) as Adjuvant Therapy for Invasive Fungal Diseases.Open Forum Infect Dis. 2022 Oct 11;9(11):ofac535. doi: 10.1093/ofid/ofac535. eCollection 2022 Nov. Open Forum Infect Dis. 2022. PMID: 36381625 Free PMC article.
-
Recent publications by ochsner authors.Ochsner J. 2002 Fall;4(4):258-9. Ochsner J. 2002. PMID: 22826673 Free PMC article. No abstract available.
-
Recent publications by ochsner authors.Ochsner J. 2002 Summer;4(3):193-4. Ochsner J. 2002. PMID: 21765754 Free PMC article. No abstract available.